Cutis. 2005 Mar;75(3 Suppl):4-7; discussion 33-6.

Present and future rosacea therapy.

Source

Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.

Abstract

Despite its prevalence, rosacea has not received the same attention of researchers as other dermatologic disorders. Nevertheless, new pharmacologic and nonpharmacologic therapies for the condition continue to be developed. The future of rosacea treatment will probably involve a combination of drugs and devices. Certain core therapies (i.e., topical metronidazole, topical azelaic acid, oral tetracyclines, and topical sulfur/sodium sulfacetamide) are validated by the greatest amount of high-order clinical evidence and will undoubtedly remain first-line therapeutic choices. However, more research is necessary to validate the efficacy and safety of newer pharmacologic agents and light-based therapy. Because rosacea is a chronic condition, pharmacologic maintenance therapy is necessary to maintain remission.

PMID:: 15810803; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Medical

Rosacea - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Related citations

Review Medical treatment of rosacea with emphasis on topical therapies. [Expert Opin Pharmacother. 2004]
Review Medical treatment of rosacea with emphasis on topical therapies.
Del Rosso JQ. Expert Opin Pharmacother. 2004 Jan; 5(1):5-13.
Review A review of the diagnosis and treatment of rosacea. [Postgrad Med. 2010]
Review A review of the diagnosis and treatment of rosacea.
Scheinfeld N, Berk T. Postgrad Med. 2010 Jan; 122(1):139-43.
[Treatment of rosacea]. [Ann Dermatol Venereol. 2011]
[Treatment of rosacea].
Parodi A, Drago F, Paolino S, Cozzani E, Gallo R. Ann Dermatol Venereol. 2011 Sep; 138 Suppl 2:S158-62.
Review A status report on the medical management of rosacea: focus on topical therapies. [Cutis. 2002]
Review A status report on the medical management of rosacea: focus on topical therapies.
Del Rosso JQ. Cutis. 2002 Nov; 70(5):271-5.
Review The role of topical metronidazole in the treatment of rosacea. [Cutis. 2004]
Review The role of topical metronidazole in the treatment of rosacea.
Wolf JE Jr. Cutis. 2004 Jan; 73(1 Suppl):19-28.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Present and future rosacea therapy.
Present and future rosacea therapy.
Cutis. 2005 Mar ;75(3 Suppl):4-7; discussion 33-6.

PubMed
Understanding the motivations for recreational marijuana use among adult Canadia...
Understanding the motivations for recreational marijuana use among adult Canadians.
Subst Use Misuse. 2008 ;43(3-4):539-72; discussion 573-9, 585-7.

PubMed
Criteria for the diagnosis of alcoholism by the Criteria Committee, National Cou...
Criteria for the diagnosis of alcoholism by the Criteria Committee, National Council on Alcoholism.
Am J Psychiatry. 1972 Aug ;129(2):127-35.

PubMed
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually activ...
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.
AIDS. 2006 Feb 28 ;20(4):543-51.

PubMed
Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influe...
Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease.
J Leukoc Biol. 2010 May ;87(5):765-78. Epub 2009 Dec 10 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: